JTEC

JTEC Current Assets

The Current Assets of JTEC (3446.T) as of Oct 21, 2026 is 1.14 B JPY. In the previous year, Current Assets was 1.94 B JPY — a change of -41.16% (lower).

Current Assets

1.14 BJPY

YoY

-41.16%

Last updated:

Current Assets of JTEC is 2026 1.14 B JPY. Current Assets of JTEC was 2025 1.94 B JPY. It decreases by -41.16% lower compared to the previous year.

The JTEC Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
3.41 M JPY
Jan 1, 2020
1.21 B JPY
Jan 1, 2021
1.50 B JPY
Jan 1, 2022
1.30 B JPY
Jan 1, 2023
1.68 B JPY
Jan 1, 2024
1.82 B JPY
Jan 1, 2025
1.94 B JPY
Jan 1, 2026
1.14 B JPY
The JTEC Current Assets history
YEARCurrent AssetsYoY
1.14 BJPY-41.16%
1.94 BJPY+6.82%
1.82 BJPY+8.25%
1.68 BJPY+28.70%
1.30 BJPY-13.10%
1.50 BJPY+23.77%
1.21 BJPY+35,468.21%
3.41 MJPY-55.01%
7.57 MJPY-98.43%
480.86 MJPY+25.05%
384.55 MJPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JTEC Stock analysis

What does JTEC do? JTEC Corp generates revenue through its two business segments. The Optical segment sells X-ray nano-collecting mirrors for synchrotron radiation and X-ray free electron laser facilities, targeting research institutions and companies in basic and industrial research. The Life Science and Equipment Development segment offers automatic cell culture devices and other automation equipment, primarily to medical, biotechnology sectors, and research institutes. Both segments develop and sell proprietary products alongside outsourced manufacturing services. The Optical segment focuses on specialized mirrors for advanced analyzers used in scientific research, while the Life Science segment provides automation solutions for cell culture processes. These products serve a range of applications from fundamental research to industrial uses, with sales directed to research organizations and industry partners in biotechnology and medical fields. JTEC Corp's revenue streams include direct sales of X-ray mirrors and cell culture devices, as well as outsourced manufacturing for proprietary products. The company's target customers are research institutions, biotechnology firms, and medical companies requiring advanced automation and precision equipment for their operations. JTEC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JTEC stock

Current Assets of JTEC is 1.14 B JPY in 2026.

Current Assets of JTEC changed from 1.94 B JPY to 1.14 B JPY, representing a -41.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets JTEC since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's JTEC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JTEC

All Key Metrics — JTEC